Remdesivir Gets Emergency Use Amid COVID-19 Push
The FDA announced emergency use of remdesivir from Gilead Sciences after a trial with 1,063 patients showed a 31 percent faster recovery. Treated patients left the hospital in 11 days versus 15 days for those not given the drug. Gilead plans production expansion and stock donation as regulators call for streamlined drug approvals for vaccines and therapies.
MENTIONED IN THIS ARTICLE
Food and Drug Administration
FDA
Gilead Sciences
Gilead
Congress
Letter to the Editor: COVID-19 not Trump’s Chernobyl
A reader rejects media comparisons between the coronavirus and the Chernobyl disaster. The letter argues radiation is detectable and noncontagious, while COVID-19 is highly contagious and global. It notes radiation incidents had limited direct deaths and cites Fukushima and Wuhan virus differences.
MENTIONED IN THIS ARTICLE
Chernobyl
Eurasia
Trump
China
Fukushima
Japan
CCP
China Communist Party
Lockdown debate shifts as pandemic measures wane
Rich Lowry argues that lockdowns aimed to flatten the curve succeeded in preventing hospital overload. He notes shifts in rhetoric toward eradicating cases, cites state cases trends, and contrasts Florida's reopening with others, urging recognition of balance between economy and health.
MENTIONED IN THIS ARTICLE
New York
New Jersey
Vox
New York Times
Guardian
Trump
White House
Food and Drug Administration
Scott Gottlieb
Sean Trende
RealClearPolitics
Minnesota
Virginia
Delaware
Iowa
Indiana
Alaska
Montana
Idaho
Hawaii
Louisiana
Michigan
Oklahoma
Ron DeSantis
Florida
Massachusetts
New Mexico Auditor urges cautious reopening amid COVID-19
State Auditor Brian Colón argues for a cautious, phased reopening as Governor Grisham leads an Economic Recovery Council. He cites unity across parties, state efforts to curb the virus, and vigilant oversight to prevent fraud while Parks reopen and non essential retail resumes curbside and delivery orders. The column aligns with a shared drive to reopen responsibly.
MENTIONED IN THIS ARTICLE
New Mexico
Grants
Michelle Susan Grisham
Bene
Economic Recovery Council
Busi
Ness
Roswell Daily Record Seeks Letters to the Editor
The Roswell Daily Record invites letters from readers with real name and city, a verifiable phone number, and optional contact for questions. Letters should be under 250 words, may be edited if over 400 words, and must avoid libelous or inappropriate content. Submissions accepted by email or at 2301 N. Main St Roswell NM 88202.
MENTIONED IN THIS ARTICLE
New Mexico
USA
Roswell
N.M
The
Roswell Daily Record
Daily Record
N. Main St
P.O
Also Mentioned on This Page
Warren Tribune Chronicle
Barbara Beck
Rdrnews
Sara Lei
Fajardo
Rdrnews.com
Manny Gonzalez
Jim Dishman
Jdishman
John Dilmore
Misty Choy
Aric Loomis
Aloomis
News and Business
Rdmnews.com
Gov. DeSantis
Wall Street Journal
Rich Lowry
National Review
Vietis
Don Shula
Andrans
Membel
Office of the State Auditor
Brian Colon
RDR